1. Home
  2. DAL vs ONC Comparison

DAL vs ONC Comparison

Compare DAL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delta Air Lines Inc.

DAL

Delta Air Lines Inc.

HOLD

Current Price

$87.41

Market Cap

38.2B

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$315.78

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAL
ONC
Founded
1924
2010
Country
United States
Switzerland
Employees
78400
12000
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2B
31.4B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
DAL
ONC
Price
$87.41
$315.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
10
Target Price
$79.26
$385.10
AVG Volume (30 Days)
6.5M
346.3K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
1.13%
N/A
EPS Growth
43.71
N/A
EPS
2.00
N/A
Revenue
$41,244,000,000.00
N/A
Revenue This Year
$3.47
$723.76
Revenue Next Year
$3.97
$15.04
P/E Ratio
$44.39
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$51.23
$253.95
52 Week High
$95.68
$385.22

Technical Indicators

Market Signals
Indicator
DAL
ONC
Relative Strength Index (RSI) 53.99 53.75
Support Level $80.64 $304.87
Resistance Level $95.68 $315.96
Average True Range (ATR) 2.20 8.16
MACD 0.03 -0.43
Stochastic Oscillator 78.23 39.30

Price Performance

Historical Comparison
DAL
ONC

About DAL Delta Air Lines Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: